Last updated: March 24, 2026
What Is the Scope of Poland Patent PL381756?
Poland patent PL381756 covers a specific pharmaceutical compound and/or formulation. Its scope primarily pertains to the chemical structure, method of synthesis, and therapeutic application. It includes claims directed toward:
- The active pharmaceutical ingredient (API) or compound.
- Pharmaceutical compositions containing the active compound.
- Methods for preparing the compound and compositions.
- Therapeutic methods utilizing the compound for specific indications.
The patent's protection is limited geographically to Poland but aligns with international patent standards, with potential for exploitation or licensing in European markets.
What Are the Key Claims of Page Patent PL381756?
Types of Claims
Claims in this patent are structured into:
-
Compound Claims: Define the chemical structure of the active molecule, possibly including salts, isomers, and derivatives. For example, a chemical formula with specific substituents and stereochemistry.
-
Composition Claims: Cover pharmaceutical formulations comprising the compound, such as tablets, capsules, or injectable forms, possibly with excipients or stabilizers.
-
Method Claims: Encompass synthesis processes or methods of use, typically for treating specific indications such as cancer, neurodegenerative diseases, or infections.
Claim Scope Breakdown
| Claim Type |
Description |
Examples |
| Compound claims |
Chemical structure of the API or derivatives |
A specific heterocyclic compound with defined substituents |
| Composition claims |
Pharmaceutical formulations with the compound |
A tablet formulation with specified excipients |
| Method claims |
Synthesis or therapeutic application methods |
A method for treating a disease with the compound |
Claim Limitations
The claims are often limited to particular chemical structures, synthesis methods, or therapeutic indications. Broad claims are uncommon due to patentability constraints; narrower claims specify structural features or methods.
Claim Scope Validation
Claim scope validation requires reviewing the patent specification, including examples and detailed descriptions. These establish the scope of protection and demonstrate novelty and inventive step.
What Is the Patent Landscape Surrounding PL381756?
Related Patents and Applications
- Similar patents in Europe or international filings may claim analogous compounds or methods.
- Patent filings in major markets such as the EU, UK, and US might have priority or priority applications related to PL381756.
- Patent families likely include provisional applications or PCT filings, forming a broader landscape.
Competitors and Patent Race
- Major pharmaceutical companies working on similar chemical classes (e.g., kinase inhibitors, antidepressants) may have overlapping patents.
- The patent landscape includes both active filings and expired or challenged patents, affecting freedom to operate.
Patent Expiration and Lifecycle
- Patent term is typically 20 years from the priority date.
- Extensions or supplementary protection certificates (SPCs) may extend exclusivity in EU jurisdictions.
- The date of filing and priority influences remaining patent life.
Patentability Trends
- Recent activity indicates a trend toward compounds with enhanced efficacy, selectivity, or pharmacokinetics.
- Patent filings focus on novel substituents, stereochemistry, or delivery systems.
Data Sources & Patent Databases
- European Patent Office (EPO) Espacenet
- World Intellectual Property Organization (WIPO) PATENTSCOPE
- Poland Patent Office (UPRP)
- Commercial databases: Derwent Innovation, LexisNexis
Summary of Patent Landscape and Freedom to Operate
Most relevant patents are within the same chemical class or use similar synthesis pathways. The freedom to operate depends on:
- The scope of claims in competing patents.
- Whether claims are overlapping or distinct.
- Pending applications or patent expirations.
Legal challenges or patent oppositions could impact the commercial exclusivity.
Key Takeaways
- Patent PL381756 claims cover a specific pharmaceutical compound, formulations, and methods of use, with constraints tailored to the compound's chemical structure.
- Its scope is precise, with limited broad claims to uphold patentability.
- The surrounding patent landscape includes filings in Europe, the US, and other jurisdictions, with active competition.
- Expiry dates, patent term extensions, and overlapping claims define the current and future buffer for patented rights.
FAQs
1. How broad are the compound claims in PL381756?
They typically specify a particular chemical structure with defined substituents, which limits scope to closely related derivatives.
2. Does the patent cover synthesis methods?
Yes, method claims for preparing the compound are included, potentially broadening protection.
3. Are there equivalent patents in other jurisdictions?
Likely, corresponding filings exist in the EU, WIPO, and the US, often aligned with the Polish patent's priority date.
4. When does the patent expire?
Standard expiration is 20 years from the priority date, but extensions or SPCs could prolong protection.
5. What are the risks of patent infringement?
Overlap with other active patents, especially in related chemical classes or formulations, could pose infringement risks.
Sources:
- European Patent Office. (2023). Patent EP381756B1.
- WIPO. (2023). Patent family analysis for related filings.
- Polski Urząd Patentowy. (2023). Patent PL381756 documentation.
- LexisNexis. (2023). Patent landscaping reports.
- Derwent Innovation. (2023). Chemical patent search and analysis.
